Learn with Anil · APPSC Group-I PYQsPractise online →Subscribe ₹149
LVM3 lifting off with Chandrayaan-3 from Sriharikota, Andhra Pradesh

Photo: LVM3 launch, Sriharikota, ISRO, GODL-India

APPSC Group-I Mains 2025 · Paper V

2025 Paper V · Q12(a): model answer

Science, Technology & Environmental Issues · Biotechnology and health. Held in May 2025 (Notification 12/2023).

Q12(a)10 marks2025 · Paper V

Explain the regulatory framework governing genetically modified organisms in India and assess its adequacy in addressing modern challenges.

Syllabus: Biotechnology and health · Biotechnology

Model answer · free

GMO regulationRules 1989GEACGenome editing

Genetically modified organisms (GMOs) are regulated in India under the Rules, 1989 for hazardous micro-organisms and genetically engineered organisms, framed under the Environment (Protection) Act, 1986. The system works through six competent authorities, from institutional committees to the Genetic Engineering Appraisal Committee (GEAC), and follows the precautionary principle and the Cartagena Protocol on Biosafety (2000), which requires the importing country's advance informed agreement before living modified organisms meant for release into the environment cross borders.

1. The regulatory framework

Institutional Biosafety Committee: lab work
RCGM (DBT): research and confined trials
GEAC (MoEFCC): environmental release
State and district committees: monitoring
FSSAI: safety of GM food
Path of a GM crop to the field
  • Six authorities: RDAC (advisory), the IBSC at each institution, RCGM under DBT, GEAC under MoEFCC (renamed from "Approval" to "Appraisal" in 2010), State Biotechnology Coordination Committees and District-Level Committees.
  • Other laws: FSSAI regulates GM food under the Food Safety and Standards Act, 2006; the PPV&FR Act, 2001 protects farmers' seed rights; the Biological Diversity Act, 2002 governs access to bio-resources.
  • Genome editing: since 30 March 2022, SDN-1 and SDN-2 edited plants free of foreign DNA are exempt from the 1989 Rules once an IBSC certifies them; SDN-3 still follows the GEAC route.

2. Record so far

  • Bt cotton (2002): the only commercial GM crop; it cut bollworm attacks, but pink bollworm now resists it and herbicide-tolerant (HTBt) cotton is sown illegally.
  • Bt brinjal: under moratorium since 2010 after public consultations.
  • GM mustard DMH-11: cleared by GEAC in 2022; the Supreme Court gave a split verdict (23 July 2024) and asked the Centre for a national GM-crop policy; release remains on hold.
  • Genome-edited rice: Kamala and Pusa DST Rice 1, released on 4 May 2025, took the lighter SDN route.

3. Adequacy for modern challenges

ChallengeGap in the present framework
Genome editing, synthetic biology, gene drivesRules written in 1989 for transgenics; no clear rules for new tools
Illegal GM seeds (HTBt cotton)Weak state and district monitoring and enforcement
Public trustBiosafety data not fully public; conflict-of-interest rules tightened only in 2025
Food and tradeLimited labs to test GM content in food, feed and seed
LiabilityNo law on redress for GM contamination
Policy vacuumNo national GM policy yet; the BRAI Bill, 2013 lapsed
Modern challenges and gaps
  • Strengths: a tiered, science-based and precautionary system, aligned with Cartagena; the editing exemption has already enabled innovation.
  • Weaknesses: slow, opaque decisions often overruled politically; DBT both promotes and regulates biotechnology; States, which control agriculture, have only a limited role.

4. Way forward

  • Statutory regulator: an independent, transparent biotechnology regulator with time-bound decisions.
  • National GM policy: prepared after consulting States, farmers and scientists, as the Supreme Court asked.
  • Risk-based rules: product-focused assessment for edited crops, strong post-release monitoring, liability and labelling.

AP angle: as a major cotton and rice State, AP has a stake in both routes: its cotton farmers grow Bt hybrids, and India's genome-edited rice varieties were bred from AP-developed parents, Samba Mahsuri (Bapatla) and MTU 1010 (Maruteru).

The 1989 framework has kept India cautious and safe, but it is outdated for gene editing and synthetic biology; a transparent, statutory system can balance biosafety with innovation.

The other choice in Q12

Answer either one in the exam.

  1. Q12(b)Trace the evolution of India's National Biotechnology Development Strategy (NBDS) and discuss its key objectives. Critically evaluate its impact on the growth of the biotechnology sector in India.

    10 marks · Biotechnology and health · Biotechnology

Write better answers: the Answer Writing Tool Kit

Every model answer on these pages is free to read. The Tool Kit adds four PDF books for Mains Papers I–IV: every previous question sorted by syllabus, with practice questions. It is in the ₹149 All-in-One Pass, with every previous paper of every exam on the site, practice quizzes, timed tests, mock test series and study books.

₹149 · valid for 12 months from the day you pay, on every exam · pay by UPI, card or net banking

Get it for ₹149